Inventaire - your friends and communities are your best library - Inventaire

Stem cells. U.S. regulation of stem cells as medical products.

Author

Douglas Sipp

Leigh G. Turner

published in: Science

date of publication: 2012-12-01

language: English

Bibliographic databases:

Cites articles 11

Date

Title

Authors

2006-10-01

FDA regulation of stem-cell-based therapies
2010-09-01

Defining the risks of mesenchymal stromal cell therapy

, ,
2010-04-24

Time-dependent fate of transplanted neural precursor cells in experimental autoimmune encephalomyelitis mice
2010-06-17

Angiomyeloproliferative lesions following autologous stem cell therapy
2011-12-07

Catastrophic demyelinating encephalomyelitis after intrathecal and intravenous stem cell transplantation in a patient with multiple sclerosis
2011-09-01

Are you "tilting at windmills" or undertaking a valid clinical trial?
2012-10-25

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

, ,
2012-04-01

Stem cells. Texas Medical Board approves rules for controversial treatment
2012-06-01

The promise and perils of stem cell therapeutics
2012-04-11

China's stem-cell rules go unheeded
2012-09-01

Conservation: Tourism ban won't help Indian tigers

Article -

Welcome to Inventaire

the library of your friends and communities

you are offline